

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.69612846 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 5.40830427 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 5.40830427 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.40830427 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.40830427 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.40830427 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.40830427 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.57520151 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.22175087 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 4.13057780 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.08281622 |
| 12 | oligosaccharide catabolic process (GO:0009313) | 3.92811750 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 3.88305563 |
| 14 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.82323764 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.75628661 |
| 16 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.73395042 |
| 17 | glycolipid catabolic process (GO:0019377) | 3.66687297 |
| 18 | positive regulation of interferon-alpha production (GO:0032727) | 3.56059295 |
| 19 | positive regulation of mast cell degranulation (GO:0043306) | 3.55864277 |
| 20 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.55864277 |
| 21 | response to host immune response (GO:0052572) | 3.46798908 |
| 22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.46798908 |
| 23 | regulation of interferon-alpha production (GO:0032647) | 3.39159170 |
| 24 | pinocytosis (GO:0006907) | 3.35744959 |
| 25 | ceramide catabolic process (GO:0046514) | 3.35062603 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.33968287 |
| 27 | positive regulation of interferon-beta production (GO:0032728) | 3.33437317 |
| 28 | microglial cell activation (GO:0001774) | 3.32582193 |
| 29 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.31125171 |
| 30 | detection of other organism (GO:0098543) | 3.30916929 |
| 31 | positive regulation of B cell differentiation (GO:0045579) | 3.21226492 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 3.20783897 |
| 33 | B cell mediated immunity (GO:0019724) | 3.19426509 |
| 34 | respiratory burst (GO:0045730) | 3.18949571 |
| 35 | natural killer cell mediated immunity (GO:0002228) | 3.16316564 |
| 36 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.16316564 |
| 37 | positive regulation of antigen processing and presentation (GO:0002579) | 3.16280054 |
| 38 | myeloid cell activation involved in immune response (GO:0002275) | 3.14903358 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.14838003 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.14838003 |
| 41 | response to host (GO:0075136) | 3.13134579 |
| 42 | response to host defenses (GO:0052200) | 3.13134579 |
| 43 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.13134579 |
| 44 | regulation of T cell tolerance induction (GO:0002664) | 3.12748567 |
| 45 | regulation of mononuclear cell migration (GO:0071675) | 3.12164796 |
| 46 | response to peptidoglycan (GO:0032494) | 3.09064683 |
| 47 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.07857707 |
| 48 | positive regulation of leukocyte degranulation (GO:0043302) | 3.07391862 |
| 49 | T-helper 1 type immune response (GO:0042088) | 3.06953791 |
| 50 | myeloid dendritic cell differentiation (GO:0043011) | 3.06638678 |
| 51 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06240298 |
| 52 | regulation of cholesterol storage (GO:0010885) | 3.05352855 |
| 53 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.04837679 |
| 54 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03683464 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 3.03459859 |
| 56 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.02567578 |
| 57 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.01922154 |
| 58 | N-acetylneuraminate metabolic process (GO:0006054) | 3.01483618 |
| 59 | regulation of hypersensitivity (GO:0002883) | 3.01395336 |
| 60 | response to muramyl dipeptide (GO:0032495) | 3.00546378 |
| 61 | detection of external biotic stimulus (GO:0098581) | 3.00336111 |
| 62 | detection of bacterium (GO:0016045) | 2.99396914 |
| 63 | regulation of tolerance induction (GO:0002643) | 2.98271269 |
| 64 | germinal center formation (GO:0002467) | 2.97826155 |
| 65 | negative regulation of T cell mediated immunity (GO:0002710) | 2.95543831 |
| 66 | neutrophil activation (GO:0042119) | 2.94703693 |
| 67 | NIK/NF-kappaB signaling (GO:0038061) | 2.93717370 |
| 68 | negative thymic T cell selection (GO:0045060) | 2.92749185 |
| 69 | granulocyte activation (GO:0036230) | 2.90955536 |
| 70 | regulation of interferon-beta production (GO:0032648) | 2.87181881 |
| 71 | negative regulation of interleukin-12 production (GO:0032695) | 2.86010819 |
| 72 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85635437 |
| 73 | purine nucleobase biosynthetic process (GO:0009113) | 2.85417315 |
| 74 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.85401878 |
| 75 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.84756003 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.84556498 |
| 77 | negative T cell selection (GO:0043383) | 2.84491198 |
| 78 | mannose metabolic process (GO:0006013) | 2.84233368 |
| 79 | response to thyroid hormone (GO:0097066) | 2.82478588 |
| 80 | macrophage activation (GO:0042116) | 2.80048260 |
| 81 | regulation of B cell differentiation (GO:0045577) | 2.79222270 |
| 82 | detection of biotic stimulus (GO:0009595) | 2.79194378 |
| 83 | regulation of interleukin-12 production (GO:0032655) | 2.79169291 |
| 84 | negative regulation of interleukin-17 production (GO:0032700) | 2.78810072 |
| 85 | defense response to protozoan (GO:0042832) | 2.77640338 |
| 86 | positive thymic T cell selection (GO:0045059) | 2.76804717 |
| 87 | cellular response to ethanol (GO:0071361) | 2.75907197 |
| 88 | cellular extravasation (GO:0045123) | 2.75540243 |
| 89 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.75346586 |
| 90 | amino sugar catabolic process (GO:0046348) | 2.73357558 |
| 91 | regulation of mast cell activation (GO:0033003) | 2.72742458 |
| 92 | activated T cell proliferation (GO:0050798) | 2.72117470 |
| 93 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.72046271 |
| 94 | positive regulation of mast cell activation (GO:0033005) | 2.71951262 |
| 95 | folic acid transport (GO:0015884) | 2.71867432 |
| 96 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.71010486 |
| 97 | response to protozoan (GO:0001562) | 2.69973550 |
| 98 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.69611390 |
| 99 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.69517567 |
| 100 | regulation of mast cell degranulation (GO:0043304) | 2.66226421 |
| 101 | neutrophil mediated immunity (GO:0002446) | 2.66167303 |
| 102 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.65449929 |
| 103 | regulation of antigen processing and presentation (GO:0002577) | 2.64882078 |
| 104 | ribosome assembly (GO:0042255) | 2.63361646 |
| 105 | leukocyte aggregation (GO:0070486) | 2.62436664 |
| 106 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.61552547 |
| 107 | regulation of gamma-delta T cell activation (GO:0046643) | 2.61528696 |
| 108 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.58889056 |
| 109 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.57038042 |
| 110 | mitotic metaphase plate congression (GO:0007080) | 2.56851298 |
| 111 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.55081191 |
| 112 | leukocyte mediated cytotoxicity (GO:0001909) | 2.54935669 |
| 113 | B cell receptor signaling pathway (GO:0050853) | 2.54919428 |
| 114 | regulation of RIG-I signaling pathway (GO:0039535) | 2.51739090 |
| 115 | lymphocyte mediated immunity (GO:0002449) | 2.51486331 |
| 116 | superoxide anion generation (GO:0042554) | 2.49988571 |
| 117 | negative regulation of mast cell activation (GO:0033004) | 2.49938761 |
| 118 | nucleobase biosynthetic process (GO:0046112) | 2.47380280 |
| 119 | T cell migration (GO:0072678) | 2.45486293 |
| 120 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.45368749 |
| 121 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.43198228 |
| 122 | DNA replication checkpoint (GO:0000076) | 2.42214497 |
| 123 | interferon-gamma production (GO:0032609) | 2.41765756 |
| 124 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.38847094 |
| 125 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.38847094 |
| 126 | folic acid metabolic process (GO:0046655) | 2.38411984 |
| 127 | regulation of translation in response to stress (GO:0043555) | 2.38375249 |
| 128 | formation of translation preinitiation complex (GO:0001731) | 2.36454729 |
| 129 | positive regulation of isotype switching (GO:0045830) | 2.36445520 |
| 130 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.36128766 |
| 131 | glycosphingolipid catabolic process (GO:0046479) | 2.35738254 |
| 132 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.34852520 |
| 133 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.34349403 |
| 134 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.32932515 |
| 135 | regulation of response to interferon-gamma (GO:0060330) | 2.32661016 |
| 136 | regulation of spindle organization (GO:0090224) | 2.30951695 |
| 137 | mast cell activation (GO:0045576) | 2.30238405 |
| 138 | mature B cell differentiation (GO:0002335) | 2.29999048 |
| 139 | cytokine secretion (GO:0050663) | 2.29379946 |
| 140 | myeloid leukocyte activation (GO:0002274) | 2.29276769 |
| 141 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.28781011 |
| 142 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.27981572 |
| 143 | positive regulation of T cell apoptotic process (GO:0070234) | 2.27477331 |
| 144 | termination of RNA polymerase I transcription (GO:0006363) | 2.27447515 |
| 145 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.27027361 |
| 146 | myeloid dendritic cell activation (GO:0001773) | 2.26796314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.97499791 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.57668682 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.92263119 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.39119948 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.93717502 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.83821550 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80772249 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.77892513 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.72858926 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.56594930 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.53377924 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.52210172 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.50048315 |
| 14 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.49657541 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47368273 |
| 16 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.46150972 |
| 17 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36034861 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.34635572 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.33512551 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.13830773 |
| 21 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10373784 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.01233859 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.00517432 |
| 24 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.99915616 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.99771093 |
| 26 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99483239 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.97602130 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.94022994 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.93808445 |
| 30 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.92572308 |
| 31 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.91199769 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.90426248 |
| 33 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89916312 |
| 34 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.87676966 |
| 35 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.87458709 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86578240 |
| 37 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.80839201 |
| 38 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.79192296 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79175325 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.73527549 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73240267 |
| 42 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72905627 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.72008730 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.70444723 |
| 45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.67531986 |
| 46 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66790217 |
| 47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.65352108 |
| 48 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56162660 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.56076545 |
| 50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53797714 |
| 51 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.53349125 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52587874 |
| 53 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.51158093 |
| 54 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.50913882 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.50709108 |
| 56 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.49623029 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49601357 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.48287613 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.46730098 |
| 60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.45911424 |
| 61 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.44496832 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.44488842 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.43381174 |
| 64 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41138489 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40190231 |
| 66 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38341204 |
| 67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.37514467 |
| 68 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.36630149 |
| 69 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.35821028 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.35734860 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32280424 |
| 72 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29844809 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28379897 |
| 74 | MAF_26560356_Chip-Seq_TH1_Human | 1.27622396 |
| 75 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.26840384 |
| 76 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26519475 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26388857 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24388630 |
| 79 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23872729 |
| 80 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22814611 |
| 81 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.22661481 |
| 82 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.20623962 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20548188 |
| 84 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.19766023 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19258685 |
| 86 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.17596499 |
| 87 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.15502655 |
| 88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14574380 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13528445 |
| 90 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.13109982 |
| 91 | MAF_26560356_Chip-Seq_TH2_Human | 1.12136558 |
| 92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.11753556 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11294829 |
| 94 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11112046 |
| 95 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10910223 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09234263 |
| 97 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.08165382 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07799019 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07031010 |
| 100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06711925 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06082897 |
| 102 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05441588 |
| 103 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05414690 |
| 104 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.05186635 |
| 105 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02131642 |
| 106 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01746281 |
| 107 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01665480 |
| 108 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01663974 |
| 109 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.01081481 |
| 110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00992004 |
| 111 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.00266181 |
| 112 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00052500 |
| 113 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99876164 |
| 114 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99668889 |
| 115 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99539284 |
| 116 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.98996093 |
| 117 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98920593 |
| 118 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98755357 |
| 119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98189708 |
| 120 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98166135 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97493890 |
| 122 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95216272 |
| 123 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93452018 |
| 124 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92541579 |
| 125 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91954186 |
| 126 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85003344 |
| 127 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.82230205 |
| 128 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81507147 |
| 129 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80168858 |
| 130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76071589 |
| 131 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75809940 |
| 132 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.74542918 |
| 133 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73359459 |
| 134 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.73262033 |
| 135 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.69963139 |
| 136 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67741702 |
| 137 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.66334626 |
| 138 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.64529570 |
| 139 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.64507045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.73665147 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.68710693 |
| 3 | MP0003693_abnormal_embryo_hatching | 2.91522322 |
| 4 | MP0008260_abnormal_autophagy | 2.86141275 |
| 5 | MP0003436_decreased_susceptibility_to | 2.85033560 |
| 6 | MP0006082_CNS_inflammation | 2.84921785 |
| 7 | MP0005671_abnormal_response_to | 2.78058887 |
| 8 | MP0002419_abnormal_innate_immunity | 2.65825667 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.51047634 |
| 10 | * MP0002452_abnormal_antigen_presenting | 2.39957399 |
| 11 | MP0009785_altered_susceptibility_to | 2.39011200 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.36033217 |
| 13 | MP0009840_abnormal_foam_cell | 2.33719718 |
| 14 | MP0005025_abnormal_response_to | 2.32359338 |
| 15 | * MP0001800_abnormal_humoral_immune | 2.31862430 |
| 16 | MP0003303_peritoneal_inflammation | 2.28814812 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.27729256 |
| 18 | * MP0002723_abnormal_immune_serum | 2.26197878 |
| 19 | MP0000569_abnormal_digit_pigmentation | 2.20795297 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.15471505 |
| 21 | * MP0001819_abnormal_immune_cell | 2.12254289 |
| 22 | * MP0002420_abnormal_adaptive_immunity | 2.11327219 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.10490937 |
| 24 | MP0003111_abnormal_nucleus_morphology | 2.08834738 |
| 25 | MP0005387_immune_system_phenotype | 2.05810725 |
| 26 | MP0001790_abnormal_immune_system | 2.05810725 |
| 27 | MP0005464_abnormal_platelet_physiology | 2.04817873 |
| 28 | MP0000685_abnormal_immune_system | 1.96644043 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.85486255 |
| 30 | MP0003724_increased_susceptibility_to | 1.84548812 |
| 31 | MP0009278_abnormal_bone_marrow | 1.84178546 |
| 32 | MP0002398_abnormal_bone_marrow | 1.82295652 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.82262086 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.82262086 |
| 35 | MP0002405_respiratory_system_inflammati | 1.77742673 |
| 36 | * MP0000716_abnormal_immune_system | 1.74148528 |
| 37 | * MP0000689_abnormal_spleen_morphology | 1.70447277 |
| 38 | MP0010094_abnormal_chromosome_stability | 1.64078979 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.62540273 |
| 40 | MP0002722_abnormal_immune_system | 1.62466070 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.61474460 |
| 42 | MP0010307_abnormal_tumor_latency | 1.60502014 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.60296179 |
| 44 | MP0005310_abnormal_salivary_gland | 1.57500733 |
| 45 | MP0001853_heart_inflammation | 1.56131717 |
| 46 | MP0003077_abnormal_cell_cycle | 1.55977047 |
| 47 | MP0008058_abnormal_DNA_repair | 1.55544733 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.54229306 |
| 49 | MP0008057_abnormal_DNA_replication | 1.53944290 |
| 50 | MP0004957_abnormal_blastocyst_morpholog | 1.53561055 |
| 51 | MP0003448_altered_tumor_morphology | 1.51375759 |
| 52 | * MP0002429_abnormal_blood_cell | 1.50287744 |
| 53 | MP0003075_altered_response_to | 1.49280719 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.48272671 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.46538078 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.43614672 |
| 57 | MP0003763_abnormal_thymus_physiology | 1.43594730 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.42922566 |
| 59 | MP0004947_skin_inflammation | 1.42206346 |
| 60 | MP0000490_abnormal_crypts_of | 1.42019745 |
| 61 | MP0008469_abnormal_protein_level | 1.34687693 |
| 62 | MP0005451_abnormal_body_composition | 1.33568537 |
| 63 | MP0010155_abnormal_intestine_physiology | 1.32582210 |
| 64 | MP0004510_myositis | 1.26133846 |
| 65 | MP0003195_calcinosis | 1.23137551 |
| 66 | MP0002166_altered_tumor_susceptibility | 1.21292225 |
| 67 | MP0000858_altered_metastatic_potential | 1.20068333 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 1.16383115 |
| 69 | MP0002006_tumorigenesis | 1.16048287 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.14053094 |
| 71 | MP0004883_abnormal_blood_vessel | 1.13293354 |
| 72 | MP0008007_abnormal_cellular_replicative | 1.11340396 |
| 73 | MP0001873_stomach_inflammation | 1.09581180 |
| 74 | MP0003183_abnormal_peptide_metabolism | 1.09292928 |
| 75 | MP0003718_maternal_effect | 1.08012146 |
| 76 | MP0008004_abnormal_stomach_pH | 1.07958793 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 1.07349456 |
| 78 | MP0002132_abnormal_respiratory_system | 1.07004609 |
| 79 | MP0003329_amyloid_beta_deposits | 1.04549057 |
| 80 | MP0000371_diluted_coat_color | 1.04448762 |
| 81 | MP0003828_pulmonary_edema | 1.04380647 |
| 82 | MP0000343_altered_response_to | 1.00488149 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 0.98335590 |
| 84 | MP0003786_premature_aging | 0.93679746 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.89851011 |
| 86 | MP0005164_abnormal_response_to | 0.89758668 |
| 87 | MP0005257_abnormal_intraocular_pressure | 0.89697859 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.87567833 |
| 89 | MP0001851_eye_inflammation | 0.85264414 |
| 90 | MP0000920_abnormal_myelination | 0.84799458 |
| 91 | MP0002095_abnormal_skin_pigmentation | 0.84525207 |
| 92 | MP0001542_abnormal_bone_strength | 0.83779187 |
| 93 | MP0003795_abnormal_bone_structure | 0.82055318 |
| 94 | MP0005365_abnormal_bile_salt | 0.81962969 |
| 95 | MP0000604_amyloidosis | 0.81515693 |
| 96 | MP0003866_abnormal_defecation | 0.81344291 |
| 97 | MP0000249_abnormal_blood_vessel | 0.79649943 |
| 98 | MP0002138_abnormal_hepatobiliary_system | 0.79279778 |
| 99 | MP0009764_decreased_sensitivity_to | 0.79252943 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 0.78995373 |
| 101 | MP0005166_decreased_susceptibility_to | 0.78316611 |
| 102 | MP0000313_abnormal_cell_death | 0.78183544 |
| 103 | MP0001663_abnormal_digestive_system | 0.77755006 |
| 104 | MP0002877_abnormal_melanocyte_morpholog | 0.77677468 |
| 105 | MP0006054_spinal_hemorrhage | 0.77169538 |
| 106 | MP0003690_abnormal_glial_cell | 0.76635718 |
| 107 | MP0002933_joint_inflammation | 0.72964000 |
| 108 | MP0005647_abnormal_sex_gland | 0.71876920 |
| 109 | MP0004130_abnormal_muscle_cell | 0.69713927 |
| 110 | MP0002254_reproductive_system_inflammat | 0.68699950 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.68367430 |
| 112 | MP0000350_abnormal_cell_proliferation | 0.67540877 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.67365954 |
| 114 | MP0003300_gastrointestinal_ulcer | 0.66427098 |
| 115 | MP0005390_skeleton_phenotype | 0.65949907 |
| 116 | MP0009763_increased_sensitivity_to | 0.64596010 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.60761605 |
| 118 | MP0005165_increased_susceptibility_to | 0.58980831 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.58922211 |
| 120 | MP0004782_abnormal_surfactant_physiolog | 0.58429199 |
| 121 | MP0005621_abnormal_cell_physiology | 0.58381029 |
| 122 | MP0009115_abnormal_fat_cell | 0.57209323 |
| 123 | MP0008932_abnormal_embryonic_tissue | 0.57050152 |
| 124 | MP0001730_embryonic_growth_arrest | 0.56992955 |
| 125 | MP0008874_decreased_physiological_sensi | 0.55823769 |
| 126 | MP0000609_abnormal_liver_physiology | 0.54119541 |
| 127 | MP0003091_abnormal_cell_migration | 0.50834070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.18515385 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.38389274 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.03623211 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.66234748 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.42980244 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.40287218 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.28292300 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.11359612 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.11359612 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.11359612 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.92897112 |
| 12 | Pustule (HP:0200039) | 3.67031101 |
| 13 | Obstructive lung disease (HP:0006536) | 3.66774732 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.66774732 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.62281239 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 3.40949610 |
| 17 | Recurrent skin infections (HP:0001581) | 3.32571246 |
| 18 | Prostate neoplasm (HP:0100787) | 3.31047986 |
| 19 | Agnosia (HP:0010524) | 3.26375363 |
| 20 | Purpura (HP:0000979) | 3.18459638 |
| 21 | Disinhibition (HP:0000734) | 3.18065097 |
| 22 | Myositis (HP:0100614) | 3.14845036 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.11793125 |
| 24 | Gingivitis (HP:0000230) | 3.04848351 |
| 25 | Dysostosis multiplex (HP:0000943) | 3.04153409 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 3.03736387 |
| 27 | Recurrent viral infections (HP:0004429) | 2.97285774 |
| 28 | Mutism (HP:0002300) | 2.95810398 |
| 29 | Pulmonary infiltrates (HP:0002113) | 2.86111070 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.81725713 |
| 31 | Stomatitis (HP:0010280) | 2.77743018 |
| 32 | Birth length less than 3rd percentile (HP:0003561) | 2.77487265 |
| 33 | Petechiae (HP:0000967) | 2.69967304 |
| 34 | Basal ganglia calcification (HP:0002135) | 2.64553531 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 2.64512374 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.64512374 |
| 37 | Entropion (HP:0000621) | 2.61567528 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.60111760 |
| 39 | Optic neuritis (HP:0100653) | 2.58985749 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 2.58985749 |
| 41 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.57757292 |
| 42 | Orchitis (HP:0100796) | 2.57411831 |
| 43 | IgM deficiency (HP:0002850) | 2.56437294 |
| 44 | Cheilitis (HP:0100825) | 2.53398498 |
| 45 | Hematochezia (HP:0002573) | 2.51226627 |
| 46 | Periodontitis (HP:0000704) | 2.50597873 |
| 47 | Hepatosplenomegaly (HP:0001433) | 2.50229300 |
| 48 | Hemoptysis (HP:0002105) | 2.48385677 |
| 49 | Abnormality of the prostate (HP:0008775) | 2.47718106 |
| 50 | Osteolytic defects of the hand bones (HP:0009699) | 2.46131836 |
| 51 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.46131836 |
| 52 | Personality changes (HP:0000751) | 2.45335035 |
| 53 | Gingival bleeding (HP:0000225) | 2.41976425 |
| 54 | Glomerulonephritis (HP:0000099) | 2.41965816 |
| 55 | Axonal loss (HP:0003447) | 2.41714314 |
| 56 | Upper motor neuron abnormality (HP:0002127) | 2.37630589 |
| 57 | Leukocytosis (HP:0001974) | 2.36693143 |
| 58 | Increased IgM level (HP:0003496) | 2.36390954 |
| 59 | T lymphocytopenia (HP:0005403) | 2.36389161 |
| 60 | Abnormality of T cell number (HP:0011839) | 2.30784730 |
| 61 | Increased serum ferritin (HP:0003281) | 2.30538703 |
| 62 | Impulsivity (HP:0100710) | 2.29255043 |
| 63 | Cellulitis (HP:0100658) | 2.28831166 |
| 64 | Neurofibrillary tangles (HP:0002185) | 2.27294133 |
| 65 | Abnormality of eosinophils (HP:0001879) | 2.26835492 |
| 66 | Meningitis (HP:0001287) | 2.26738225 |
| 67 | IgG deficiency (HP:0004315) | 2.25224977 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.23755733 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.21757157 |
| 70 | Eosinophilia (HP:0001880) | 2.20488244 |
| 71 | Vasculitis (HP:0002633) | 2.19621910 |
| 72 | Urticaria (HP:0001025) | 2.19432955 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.18794863 |
| 74 | Conjunctival telangiectasia (HP:0000524) | 2.18768728 |
| 75 | Metaphyseal irregularity (HP:0003025) | 2.17634270 |
| 76 | Ureteral duplication (HP:0000073) | 2.17571842 |
| 77 | Rough bone trabeculation (HP:0100670) | 2.17305807 |
| 78 | Chronic otitis media (HP:0000389) | 2.14627222 |
| 79 | Global brain atrophy (HP:0002283) | 2.13915990 |
| 80 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.13604333 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 2.13414892 |
| 82 | Prolonged neonatal jaundice (HP:0006579) | 2.12941421 |
| 83 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.12566779 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.12566779 |
| 85 | Abnormality of T cells (HP:0002843) | 2.11010246 |
| 86 | Recurrent pneumonia (HP:0006532) | 2.08445972 |
| 87 | Encephalitis (HP:0002383) | 2.07868136 |
| 88 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05415013 |
| 89 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05415013 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05415013 |
| 91 | Polyneuropathy (HP:0001271) | 2.05008100 |
| 92 | Keratoconjunctivitis (HP:0001096) | 2.04973582 |
| 93 | Inappropriate behavior (HP:0000719) | 2.04739101 |
| 94 | Abnormality of the periventricular white matter (HP:0002518) | 2.04192712 |
| 95 | Diminished motivation (HP:0000745) | 2.04026205 |
| 96 | Gastrointestinal infarctions (HP:0005244) | 2.03149184 |
| 97 | Apathy (HP:0000741) | 2.01935115 |
| 98 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.01537375 |
| 99 | Bone marrow hypocellularity (HP:0005528) | 2.00531155 |
| 100 | Neurodegeneration (HP:0002180) | 2.00066665 |
| 101 | Inflammation of the large intestine (HP:0002037) | 1.99546423 |
| 102 | Leukopenia (HP:0001882) | 1.99011749 |
| 103 | Albinism (HP:0001022) | 1.98705231 |
| 104 | Arterial thrombosis (HP:0004420) | 1.98694825 |
| 105 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98596590 |
| 106 | Spontaneous hematomas (HP:0007420) | 1.98578086 |
| 107 | Chest pain (HP:0100749) | 1.98474021 |
| 108 | Joint swelling (HP:0001386) | 1.98450805 |
| 109 | Panhypogammaglobulinemia (HP:0003139) | 1.98313626 |
| 110 | Colitis (HP:0002583) | 1.97702416 |
| 111 | Anorexia (HP:0002039) | 1.96927540 |
| 112 | Myocardial infarction (HP:0001658) | 1.95325461 |
| 113 | Osteomyelitis (HP:0002754) | 1.94234466 |
| 114 | Amaurosis fugax (HP:0100576) | 1.93734594 |
| 115 | Epistaxis (HP:0000421) | 1.93357249 |
| 116 | Pulmonary embolism (HP:0002204) | 1.93078164 |
| 117 | Neuronal loss in central nervous system (HP:0002529) | 1.93073829 |
| 118 | Combined immunodeficiency (HP:0005387) | 1.92582903 |
| 119 | Granulocytopenia (HP:0001913) | 1.92288859 |
| 120 | Abnormality of the umbilical cord (HP:0010881) | 1.91611443 |
| 121 | Loss of speech (HP:0002371) | 1.90598143 |
| 122 | Chromsome breakage (HP:0040012) | 1.89679327 |
| 123 | Thyroiditis (HP:0100646) | 1.87912631 |
| 124 | Thoracic kyphosis (HP:0002942) | 1.87551947 |
| 125 | Progressive neurologic deterioration (HP:0002344) | 1.86602015 |
| 126 | Thrombocytosis (HP:0001894) | 1.86136302 |
| 127 | Lymphoma (HP:0002665) | 1.86129913 |
| 128 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85967439 |
| 129 | Poor head control (HP:0002421) | 1.85450693 |
| 130 | Abnormality of the anterior horn cell (HP:0006802) | 1.84941929 |
| 131 | Degeneration of anterior horn cells (HP:0002398) | 1.84941929 |
| 132 | Interstitial pulmonary disease (HP:0006530) | 1.84856128 |
| 133 | Spinal muscular atrophy (HP:0007269) | 1.84640203 |
| 134 | Abnormality of T cell physiology (HP:0011840) | 1.84467817 |
| 135 | Gastrointestinal inflammation (HP:0004386) | 1.83628559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.24065300 |
| 2 | BLK | 3.22539200 |
| 3 | MAP4K1 | 3.13420290 |
| 4 | BUB1 | 2.92971341 |
| 5 | TXK | 2.86775552 |
| 6 | WEE1 | 2.85496316 |
| 7 | IRAK4 | 2.55423534 |
| 8 | RIPK4 | 2.54800212 |
| 9 | KIT | 2.52185533 |
| 10 | TYK2 | 2.23082754 |
| 11 | ZAP70 | 2.21119660 |
| 12 | IRAK3 | 2.20774681 |
| 13 | NEK2 | 2.13217216 |
| 14 | TGFBR2 | 2.00597654 |
| 15 | EIF2AK1 | 1.87354888 |
| 16 | TBK1 | 1.81103047 |
| 17 | TSSK6 | 1.73314703 |
| 18 | FGR | 1.71869403 |
| 19 | BMPR2 | 1.71403365 |
| 20 | IKBKB | 1.68667968 |
| 21 | TEC | 1.68443873 |
| 22 | CSF1R | 1.67247432 |
| 23 | MAP3K14 | 1.64183106 |
| 24 | PRPF4B | 1.58617574 |
| 25 | MAP3K11 | 1.48358879 |
| 26 | RPS6KA4 | 1.45744164 |
| 27 | STK10 | 1.43175264 |
| 28 | ADRBK2 | 1.41303557 |
| 29 | STK16 | 1.39175360 |
| 30 | IKBKE | 1.38796155 |
| 31 | PIM2 | 1.36575703 |
| 32 | SYK | 1.35845288 |
| 33 | EIF2AK3 | 1.34393134 |
| 34 | PLK4 | 1.33269084 |
| 35 | PIM1 | 1.32508685 |
| 36 | BRSK2 | 1.31944233 |
| 37 | MAP2K3 | 1.27326449 |
| 38 | JAK3 | 1.27255796 |
| 39 | EIF2AK2 | 1.26038211 |
| 40 | MKNK2 | 1.25694634 |
| 41 | ACVR1B | 1.24136964 |
| 42 | JAK1 | 1.23739013 |
| 43 | BTK | 1.21004321 |
| 44 | NEK9 | 1.16653866 |
| 45 | HCK | 1.15506657 |
| 46 | LYN | 1.14908761 |
| 47 | ITK | 1.12471518 |
| 48 | TNK2 | 1.09292491 |
| 49 | TAOK3 | 1.08971286 |
| 50 | LCK | 1.04960790 |
| 51 | DYRK3 | 1.04742459 |
| 52 | CSK | 1.00364021 |
| 53 | NUAK1 | 0.99792185 |
| 54 | CDK4 | 0.99367225 |
| 55 | CDC42BPA | 0.97407305 |
| 56 | STK4 | 0.97032954 |
| 57 | STK3 | 0.95796457 |
| 58 | MARK3 | 0.95447355 |
| 59 | SRPK1 | 0.94995743 |
| 60 | PLK1 | 0.94854236 |
| 61 | PIK3CG | 0.93769663 |
| 62 | TAOK1 | 0.91903055 |
| 63 | CCNB1 | 0.89309571 |
| 64 | IRAK1 | 0.88006163 |
| 65 | MKNK1 | 0.86604274 |
| 66 | GRK7 | 0.85777876 |
| 67 | MAP3K1 | 0.82946483 |
| 68 | NLK | 0.81520798 |
| 69 | STK24 | 0.76764949 |
| 70 | CAMKK2 | 0.76258788 |
| 71 | CLK1 | 0.75033817 |
| 72 | PRKCQ | 0.74625507 |
| 73 | ALK | 0.73999808 |
| 74 | PDK2 | 0.73913708 |
| 75 | CDK6 | 0.73160105 |
| 76 | MAP3K3 | 0.72387763 |
| 77 | CHUK | 0.71063896 |
| 78 | FES | 0.70562129 |
| 79 | TESK2 | 0.69063542 |
| 80 | ZAK | 0.67698640 |
| 81 | AURKB | 0.67564932 |
| 82 | AKT3 | 0.66289103 |
| 83 | CAMKK1 | 0.65232177 |
| 84 | TTK | 0.64869970 |
| 85 | MAPK12 | 0.64848762 |
| 86 | DDR2 | 0.64839402 |
| 87 | MAP3K13 | 0.63911297 |
| 88 | JAK2 | 0.62514729 |
| 89 | ATR | 0.60339038 |
| 90 | MAP3K8 | 0.58465690 |
| 91 | MOS | 0.57766294 |
| 92 | CAMK1D | 0.57671939 |
| 93 | SIK3 | 0.57449187 |
| 94 | MAP2K6 | 0.56940411 |
| 95 | PBK | 0.56687607 |
| 96 | DAPK2 | 0.56454099 |
| 97 | MATK | 0.56147106 |
| 98 | CDK7 | 0.55606415 |
| 99 | PDPK1 | 0.55120044 |
| 100 | CAMK1G | 0.53695238 |
| 101 | MAPK7 | 0.52985367 |
| 102 | IRAK2 | 0.50695052 |
| 103 | TRPM7 | 0.49731374 |
| 104 | PAK4 | 0.49585679 |
| 105 | PLK3 | 0.49269751 |
| 106 | FGFR4 | 0.48731403 |
| 107 | HIPK2 | 0.47432473 |
| 108 | CHEK2 | 0.45986823 |
| 109 | RPS6KA6 | 0.45677879 |
| 110 | RPS6KL1 | 0.45622350 |
| 111 | RPS6KC1 | 0.45622350 |
| 112 | GRK6 | 0.45609932 |
| 113 | ABL1 | 0.45283635 |
| 114 | FYN | 0.45205468 |
| 115 | PRKCD | 0.44971555 |
| 116 | EPHA3 | 0.44438151 |
| 117 | ABL2 | 0.44256187 |
| 118 | YES1 | 0.42857316 |
| 119 | MELK | 0.42695093 |
| 120 | BRSK1 | 0.42057370 |
| 121 | EGFR | 0.41075378 |
| 122 | TAOK2 | 0.40055236 |
| 123 | MAP3K5 | 0.39472949 |
| 124 | MAPK4 | 0.39347633 |
| 125 | VRK1 | 0.39235295 |
| 126 | PDK1 | 0.39231637 |
| 127 | IGF1R | 0.35907605 |
| 128 | RPS6KA2 | 0.35658109 |
| 129 | RPS6KA5 | 0.35616935 |
| 130 | FGFR3 | 0.34707616 |
| 131 | CSNK2A1 | 0.34563279 |
| 132 | GRK1 | 0.34305127 |
| 133 | MAPKAPK2 | 0.33558988 |
| 134 | PNCK | 0.31692172 |
| 135 | ERN1 | 0.31504464 |
| 136 | SCYL2 | 0.31441501 |
| 137 | TGFBR1 | 0.28896346 |
| 138 | SGK3 | 0.28681878 |
| 139 | MARK2 | 0.28439632 |
| 140 | EPHB1 | 0.27772918 |
| 141 | INSR | 0.27488341 |
| 142 | SGK2 | 0.27371543 |
| 143 | CAMK4 | 0.25662438 |
| 144 | BMX | 0.24589556 |
| 145 | MAPK11 | 0.23765847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.15691446 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.47623529 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 2.44966472 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.30171202 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.28775839 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.21305885 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.19900506 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.19277448 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.17784202 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.07603997 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.00902813 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.98604829 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97080805 |
| 14 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.97031450 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81474517 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78331676 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.75061162 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.71095636 |
| 19 | DNA replication_Homo sapiens_hsa03030 | 1.66720517 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.65380565 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.64385897 |
| 22 | RNA transport_Homo sapiens_hsa03013 | 1.58196465 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57630090 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57169347 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.55509846 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.55169038 |
| 27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.54317203 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.51204403 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51083730 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45186593 |
| 31 | Base excision repair_Homo sapiens_hsa03410 | 1.43199137 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.42448972 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.42355368 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38114280 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34648529 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34175303 |
| 37 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.31944061 |
| 38 | Mismatch repair_Homo sapiens_hsa03430 | 1.28266477 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.27570215 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.25770659 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.25200022 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.19845414 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.19540319 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.19071105 |
| 45 | Spliceosome_Homo sapiens_hsa03040 | 1.18596841 |
| 46 | Cell cycle_Homo sapiens_hsa04110 | 1.17826199 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.15711466 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07865059 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06991805 |
| 50 | Ribosome_Homo sapiens_hsa03010 | 1.05891030 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02395139 |
| 52 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.02201210 |
| 53 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.02059592 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.98688355 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97773307 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96798103 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95012412 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94933839 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92141547 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91370710 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91271146 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90340804 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86565073 |
| 64 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.85983925 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85825753 |
| 66 | Shigellosis_Homo sapiens_hsa05131 | 0.82136463 |
| 67 | Hepatitis B_Homo sapiens_hsa05161 | 0.81667787 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81341340 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77175692 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77006313 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76362464 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.75746022 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75130560 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74644754 |
| 75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.72782760 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.72476791 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70228960 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66491447 |
| 79 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66030050 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65244225 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.64733499 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62660127 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60772149 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59910637 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.55001391 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54985126 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53762526 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52544254 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51649096 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51385697 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46982733 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46636814 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46462789 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45770611 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.44580153 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44061485 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43556657 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.42186479 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.42138151 |
| 100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41560543 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40780299 |
| 102 | RNA degradation_Homo sapiens_hsa03018 | 0.40756971 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40508154 |
| 104 | Viral myocarditis_Homo sapiens_hsa05416 | 0.39778068 |
| 105 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39227252 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | 0.38730488 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38403464 |
| 108 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38086932 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37398681 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36501239 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36410596 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36186196 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35964190 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35278904 |
| 115 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.35251457 |
| 116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35237856 |
| 117 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.34839860 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34192131 |
| 119 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34018904 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30578518 |
| 121 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.30494612 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29963064 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29372872 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28080747 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26292888 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.24877137 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23525530 |
| 128 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.23050359 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.22670583 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20126743 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19795141 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.19768143 |
| 133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19080169 |
| 134 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17029578 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15988491 |

